Compare ASIC & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASIC | BLFS |
|---|---|---|
| Founded | 2018 | 1987 |
| Country | United States | United States |
| Employees | 203 | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 930.6M | 923.5M |
| IPO Year | N/A | 2013 |
| Metric | ASIC | BLFS |
|---|---|---|
| Price | $20.47 | $19.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $26.75 | ★ $32.00 |
| AVG Volume (30 Days) | 80.8K | ★ 324.6K |
| Earning Date | 05-23-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | $35.31 | $19.73 |
| Revenue Next Year | $34.70 | $17.82 |
| P/E Ratio | $98.60 | ★ N/A |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $16.35 | $17.86 |
| 52 Week High | $23.88 | $29.57 |
| Indicator | ASIC | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 54.78 | 48.69 |
| Support Level | $20.26 | $17.88 |
| Resistance Level | $20.67 | $20.47 |
| Average True Range (ATR) | 0.62 | 0.87 |
| MACD | 0.14 | 0.21 |
| Stochastic Oscillator | 73.94 | 61.37 |
Ategrity Specialty Insurance Co Holdings is a specialty property and casualty insurance holding company focused on the excess and surplus market for small to medium-sized businesses (SMBs) across the United States. Operating through its subsidiaries, the company underwrites small and medium-sized commercial risks across selected industry verticals, including Retail, Real Estate, Hospitality, and Construction. Its operating model uses a technology-driven method to standardize, simplify, and, where appropriate, automate these transactions. The group distributes its products through licensed surplus lines brokers and wholesale agents.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.